PR

April 1, 2019 -- Glucose Health, Inc. ANNUAL REPORT – Revenue Up 89%, Gross Profit Up 17%, Expenses Down 27%.

BENTONVILLE ARKANSAS – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data from its ANNUAL REPORT for the fiscal year ended December 31, 2018, posted today on OTCMarkets.com.

Fiscal year ended December 31, 2018:

  1. Fiscal 2018 Revenue of $197,500 compared with $104,522 for Fiscal 2017; an increase of 89%.
  2. Fiscal 2018 Gross Profit of $52,818 compared with $45,112 for Fiscal 2017; an increase of 17%.
  3. Total Operating Expenses of $76,304 vs. $104,522 for Fiscal 2017; a reduction of 27%.

Murray Fleming, CEO of...

Read more

March 13, 2019 -- FDA ACCEPTS CLINICAL RESEARCH UNDERLYING GLUCODOWN® DIETARY FIBER LABELING

BENTONVILLE AR – GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: “GLUC”), is the leading functional tea beverage in the over-the-counter diabetic nutritional retail category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic.1 Food and Drug Administration (“FDA”) regulations2 enacted in 2016, provide that only forms of dietary fiber demonstrating a “beneficial physiological effect on human health”, can be declared on nutritional supplement product labels, as dietary fiber. More than two years ago, a...

Read more

February 25, 2019 -- US PATENT OFFICE AWARDS GLUCODOWN® TRADEMARK FOR EXPANDED DISTRIBUTION OF NEW DIABETIC TEA FLAVORS

BENTONVILLE AR – GLUCOSE HEALTH, INC. (OTC: “GLUC”) today confirmed it has secured registration of the trademark GLUCODOWN® following a detailed review process, from the United States Patent & Trademark Office (“USPTO”). GLUCOSE HEALTH, INC. was successfully awarded the highest level of trademark protection possible from the USPTO, with registration of GLUCODOWN® on the principal register (Reg. # 5572054). Use of the GLUCODOWN trademark was first achieved outside of the United States, by HanAll Bio...

Read more

November 14, 2018 -- Glucose Health, Inc. Reports Higher Revenues & Gross Profits; Lower Operating Costs.

BENTONVILLE AR, November 14, 2018 – Glucose Health, Inc. (OTC: “GLUC”) confirms the following selected financial data for the 9-month period ended September 30, 2018 vs. the 9-month period ended September 30, 2017, posted this morning at OTCMarkets.com.

  1. Revenues of $158,482; a 117% increase compared to the prior 2017 period.
  2. Operating Expenses of $54,590; a 16% decrease compared to the prior 2017 period.
  3. Gross Profits of $86,162; a 51% increase compared to the prior 2017 period.
  4. Net Assets of $165,256; a 138%
  5. ...

Read more